| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.23 | 2e-11 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.23 | 3e-11 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.22 | 4e-11 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.19 | 1e-10 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.23 | 1e-10 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.2 | 2e-10 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.2 | 3e-10 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | 0.21 | 3e-10 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.21 | 4e-10 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.22 | 5e-10 |